Inventor
DENIS DAIGLE
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium33%
A61KPreparations for medical, dental or toiletry purposes27%
Y02ATechnologies for adaptation to climate change7%
PatentTitleYear
12,544,395Combination compositions comprising a beta-lactamase inhibitor and uses thereof202612,173,018Penicillin-binding protein inhibitors202411,414,435Beta-lactamase inhibitors202211,332,485Penicillin-binding protein inhibitors202211,267,826Penicillin-binding protein inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to VENATORX PHARMACEUTICALS INC (5)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| VENATORX PHARMACEUTICALS INC | 5 | 2022–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2026 |